Neo Ivy Capital Management Insmed Inc Transaction History
Neo Ivy Capital Management
- $293 Million
- Q1 2025
A detailed history of Neo Ivy Capital Management transactions in Insmed Inc stock. As of the latest transaction made, Neo Ivy Capital Management holds 4,452 shares of INSM stock, worth $722,648. This represents 0.12% of its overall portfolio holdings.
Number of Shares
4,452Holding current value
$722,648% of portfolio
0.12%Shares
11 transactions
Others Institutions Holding INSM
# of Institutions
581Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$3.14 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.86 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.32 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.82 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.25 Billion7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $22B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...